Использование пуповинной крови при проведении аллогенной трансплантации гемопоэтических стволовых клеток у детей (опыт работы Московского банка стволовых клеток)

Т. В. Шаманская, Tatiana A. Astrelina, З. А. Подколзина et al. · Вестник Росздравнадзора · 2010

Abstract: the results of hematopoetic stem cell transplantation (HSCT) of cord blood units collected by Stem Cell Bank of Moscow are described. From August 2006 till August 2009 16 children with malignant hematological and non-malignant diseases have undergone umbilical cord blood transplantation (UCBT). The median number of total nucleated cells and CD34 + cells infused was 6,0x107/kg (range 0,221,5) and 7,7x105/kg (range 0,5-40), accordingly. 9 patients showed engraftment. The median time to neutrophil engraftment was 24 days (range 15-36). Acute GVHD grade I-II was observed in 7 patients, there were no cases of severe GVHD. Chronic GVHD was noted in 1 patient. The transplant-related mortality at 100 days was 0,285. The overall survival was 0,562, with a median time of observation of 116 days. The results of our study showed that UCB is an alternative source of stem cells for HSCT in patients with malignant and non-malignant diseases.

Cited by 0 works.

Authors

References